Eurofins Scientific Yönetim
Yönetim kriter kontrolleri 3/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Gilles Martin
İcra Kurulu Başkanı
€1.4m
Toplam tazminat
| CEO maaş yüzdesi | 97.6% |
| CEO görev süresi | 36.8yrs |
| CEO sahipliği | 0.00001% |
| Yönetim ortalama görev süresi | Veri yok |
| Yönetim Kurulu ortalama görev süresi | 9.1yrs |
Son yönetim güncellemeleri
Recent updates
Eurofins Scientific (EPA:ERF) Seems To Use Debt Quite Sensibly
Oct 21
Earnings Tell The Story For Eurofins Scientific SE (EPA:ERF)
Aug 17Results: Eurofins Scientific SE Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 27These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Extensively
May 10We Discuss Why Eurofins Scientific SE's (EPA:ERF) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Apr 19Eurofins Scientific SE's (EPA:ERF) Price In Tune With Earnings
Apr 18Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?
Nov 10Eurofins Scientific SE's (EPA:ERF) Intrinsic Value Is Potentially 64% Above Its Share Price
Oct 23We Think Eurofins Scientific (EPA:ERF) Is Taking Some Risk With Its Debt
Aug 07Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 25%?
Jul 20We Think Eurofins Scientific (EPA:ERF) Can Stay On Top Of Its Debt
May 03Eurofins Scientific SE (EPA:ERF) Shares Could Be 21% Above Their Intrinsic Value Estimate
Apr 11Estimating The Intrinsic Value Of Eurofins Scientific SE (EPA:ERF)
Jan 05Here's Why Eurofins Scientific (EPA:ERF) Can Manage Its Debt Responsibly
Dec 14An Intrinsic Calculation For Eurofins Scientific SE (EPA:ERF) Suggests It's 33% Undervalued
Oct 03Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?
Sep 06Eurofins Scientific (EPA:ERF) Is Increasing Its Dividend To €1.00
Jun 25Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 39%?
Jun 16Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet
Jun 01Should You Be Adding Eurofins Scientific (EPA:ERF) To Your Watchlist Today?
Apr 12These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Safely
Feb 25Is Eurofins Scientific SE (EPA:ERF) Worth €114 Based On Its Intrinsic Value?
Nov 28Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet
Nov 14Here's Why I Think Eurofins Scientific (EPA:ERF) Might Deserve Your Attention Today
Sep 30Are Eurofins Scientific SE (EPA:ERF) Investors Paying Above The Intrinsic Value?
Aug 29We Think Eurofins Scientific (EPA:ERF) Can Manage Its Debt With Ease
Aug 15Do Eurofins Scientific's (EPA:ERF) Earnings Warrant Your Attention?
Jun 24Estimating The Fair Value Of Eurofins Scientific SE (EPA:ERF)
May 25Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet
Mar 31Does Eurofins Scientific (EPA:ERF) Deserve A Spot On Your Watchlist?
Mar 17Eurofins Scientific SE (EPA:ERF) Has Got What It Takes To Be An Attractive Dividend Stock
Mar 03Eurofins Scientific SE Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Mar 03Are Institutions Heavily Invested In Eurofins Scientific SE's (EPA:ERF) Shares?
Feb 15
Is Eurofins Scientific's (EPA:ERF) 117% Share Price Increase Well Justified?
Dec 28CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | €326m |
| Mar 31 2024 | n/a | n/a | €291m |
| Dec 31 2023 | €1m | €1m | €257m |
| Sep 30 2023 | n/a | n/a | €335m |
| Jun 30 2023 | n/a | n/a | €414m |
| Mar 31 2023 | n/a | n/a | €497m |
| Dec 31 2022 | €1m | €1m | €581m |
| Sep 30 2022 | n/a | n/a | €612m |
| Jun 30 2022 | n/a | n/a | €643m |
| Mar 31 2022 | n/a | n/a | €696m |
| Dec 31 2021 | €1m | €1m | €749m |
| Sep 30 2021 | n/a | n/a | €786m |
| Jun 30 2021 | n/a | n/a | €824m |
| Mar 31 2021 | n/a | n/a | €665m |
| Dec 31 2020 | €1m | €1m | €505m |
| Sep 30 2020 | n/a | n/a | €347m |
| Jun 30 2020 | n/a | n/a | €190m |
| Mar 31 2020 | n/a | n/a | €168m |
| Dec 31 2019 | €1m | €1m | €146m |
| Sep 30 2019 | n/a | n/a | €144m |
| Jun 30 2019 | n/a | n/a | €143m |
| Mar 31 2019 | n/a | n/a | €159m |
| Dec 31 2018 | €1m | €1m | €175m |
Tazminat ve Piyasa: Gilles 'nin toplam tazminatı ($USD 1.41M ), French pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 3.58M ).
Tazminat ve Kazançlar: Gilles 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Gilles Martin (61 yo)
36.8yrs
Görev süresi
€1,351,000
Tazminat
Dr. Gilles G. Martin, Ph D., serves as the Chief Executive Officer at Eurofins Scientific, Inc. Dr. Martin serves as Chief Executive Officer of Eurofins Nihon Kankyo K.K. and Eurofins Scientific Group. He...
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman of the Board & CEO | 36.8yrs | €1.35m | 0.000010% € 889.2 | |
| Executive Director | 34.8yrs | €400.69k | 0.000010% € 889.2 | |
| Non-Executive Director | 32.8yrs | €33.00k | 0.077% € 6.8m | |
| Independent Non-Executive Director | 7.6yrs | €71.50k | Veri yok | |
| Independent Non-Executive Director | 3.6yrs | €55.00k | Veri yok | |
| Independent Non-Executive Director | 10.6yrs | €44.00k | 0.0033% € 296.1k | |
| Independent Non-Executive Director | 3.6yrs | €66.00k | 0.00032% € 28.5k | |
| Lead Independent Non-Executive Director | 4.4yrs | €93.50k | Veri yok | |
| Independent Non-Executive Director | no data | Veri yok | Veri yok |
9.1yrs
Ortalama Görev Süresi
60.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: ERF 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.1 yıldır).